Based on 34 analysts giving stock ratings to Boston Scientific Corp in the past month.
In the current month, BSX has received 17 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the last month is 64.476.
Based on analysts' estimates, BSX EPS is projected to reach 0.771 in FY2026Q3, following reported EPS of 0.617 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.62, while Boston Scientific CorpBSX's earnings per share (EPS) for the previous quarter was USD 0.90. EPS for the next quarter is expected at USD 0.77.